Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 27-0097769 · Snapshot of IRS recognition, filing currency, financial health, and governance.
FY2024 filed as a Form 990-N placeholder. The IRS has not yet released this organization’s full Form 990 for FY2024. All data on this profile reflects the most recent substantive 990 filing; the placeholder year appears in the Financials tab with no breakdown.
The primary exempt purpose of the Eicosanoid Research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, Diabetes, psoriasis and Alzheimer's. This purpose is accomplished through the organization's biennial conference. The Eicosanoid Research foundation sponsors biennial conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative Research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds. The main purpose of the Eicosanoid Research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer,
Principal Officer
Charles Serhan
Total Revenue
$0
FY2024
Total Expenses
—
FY2024
Net Assets
$0
Program Ratio
—
expenses on programs
Employees
0
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.